Literature DB >> 31630152

Cardiac fibroblast activation detected by positron emission tomography/computed tomography as a possible sign of cardiotoxicity.

Matthias Totzeck1, Johannes Siebermair1, Tienush Rassaf1, Christoph Rischpler2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31630152     DOI： 10.1093/eurheartj/ehz736

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  10 in total

Review 1.  Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.

Authors:  Mengting Li; Muhsin H Younis; Yongxue Zhang; Weibo Cai; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-31       Impact factor: 10.057

2.  Imaging the Inflammatory Response in Checkpoint Inhibition Myocarditis.

Authors:  Christoph Rischpler; Tienush Rassaf; Lale Umutlu; Ken Herrmann; Thomas-Wilfried Schlosser; Matthias Totzeck
Journal:  J Nucl Med       Date:  2021-12-02       Impact factor: 11.082

Review 3.  FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century.

Authors:  Rong Huang; Yu Pu; Shun Huang; Conghui Yang; Fake Yang; Yongzhu Pu; Jindan Li; Long Chen; Yunchao Huang
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

Review 4.  Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review.

Authors:  Paul Windisch; Daniel R Zwahlen; Stefan A Koerber; Frederik L Giesel; Jürgen Debus; Uwe Haberkorn; Sebastian Adeberg
Journal:  Cancers (Basel)       Date:  2020-09-15       Impact factor: 6.639

Review 5.  Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review.

Authors:  Paul Windisch; Daniel R Zwahlen; Frederik L Giesel; Eberhard Scholz; Patrick Lugenbiel; Jürgen Debus; Uwe Haberkorn; Sebastian Adeberg
Journal:  EJNMMI Res       Date:  2021-02-19       Impact factor: 3.138

Review 6.  Nuclear Molecular Imaging of Cardiac Remodeling after Myocardial Infarction.

Authors:  Zohreh Varasteh; Wolfgang A Weber; Christoph Rischpler
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-31

Review 7.  Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.

Authors:  David Kersting; Stephan Settelmeier; Ilektra-Antonia Mavroeidi; Ken Herrmann; Robert Seifert; Christoph Rischpler
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

Review 8.  PET Tracers for Imaging Cardiac Function in Cardio-oncology.

Authors:  James M Kelly; John W Babich
Journal:  Curr Cardiol Rep       Date:  2022-01-13       Impact factor: 2.931

Review 9.  Molecular Imaging Using Cardiac PET/CT: Opportunities to Harmonize Diagnosis and Therapy.

Authors:  James T Thackeray
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

10.  Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodeling.

Authors:  J Siebermair; M I Köhler; J Kupusovic; S G Nekolla; L Kessler; J Ferdinandus; N Guberina; M Stuschke; H Grafe; J T Siveke; S Kochhäuser; W P Fendler; M Totzeck; R Wakili; L Umutlu; T Schlosser; T Rassaf; C Rischpler
Journal:  J Nucl Cardiol       Date:  2020-09-25       Impact factor: 5.952
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.